GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Cyclically Adjusted Revenue per Share

Eisai Co (TSE:4523) Cyclically Adjusted Revenue per Share : 円0.00 (As of Mar. 2024)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Eisai Co's adjusted revenue per share for the three months ended in Mar. 2024 was 円664.242. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eisai Co's average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Eisai Co was -0.70% per year. The lowest was -3.00% per year. And the median was -1.80% per year.

As of today (2024-05-15), Eisai Co's current stock price is 円6864.00. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円0.00. Eisai Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.54. The lowest was 0.64. And the median was 0.91.


Eisai Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted Revenue per Share Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,097.84 7,829.32 7,553.28 7,668.03 -

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,668.03 7,557.35 7,631.58 7,516.38 -

Competitive Comparison of Eisai Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.



Eisai Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=664.242/107.2000*107.2000
=664.242

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1,860.011 98.000 2,034.624
201409 1,902.080 98.500 2,070.081
201412 1,946.841 97.900 2,131.781
201503 1,954.675 97.900 2,140.359
201506 1,944.710 98.400 2,118.627
201509 1,903.148 98.500 2,071.243
201512 2,107.831 98.100 2,303.359
201603 1,695.201 97.900 1,856.236
201606 1,914.475 98.100 2,092.066
201609 1,856.716 98.000 2,031.020
201612 1,945.610 98.400 2,119.608
201703 1,813.579 98.100 1,981.811
201706 1,981.022 98.500 2,155.996
201709 1,999.832 98.800 2,169.858
201712 2,160.774 99.400 2,330.332
201803 2,239.795 99.200 2,420.424
201806 2,139.384 99.200 2,311.915
201809 2,188.587 99.900 2,348.514
201812 2,192.321 99.700 2,357.240
201903 2,447.327 99.700 2,631.429
201906 2,148.661 99.800 2,307.981
201909 2,027.298 100.100 2,171.092
201912 2,606.572 100.500 2,780.343
202003 2,920.723 100.300 3,121.650
202006 2,309.934 99.900 2,478.728
202009 2,113.046 99.900 2,267.453
202012 2,529.129 99.300 2,730.339
202103 2,059.263 99.900 2,209.740
202106 693.818 99.500 747.510
202109 2,280.304 100.100 2,442.044
202112 708.044 100.100 758.265
202203 665.847 101.100 706.022
202206 642.487 101.800 676.568
202209 607.928 103.100 632.104
202212 654.028 104.100 673.504
202303 691.077 104.400 709.612
202306 686.850 105.200 699.908
202309 615.832 106.200 621.631
202312 619.535 106.800 621.855
202403 664.242 107.200 664.242

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Eisai Co  (TSE:4523) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.54. The lowest was 0.64. And the median was 0.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Eisai Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (TSE:4523) Business Description

Industry
Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines